Cancer Areas Reviewed by Korean Particle Therapy Centers
Based on publicly available hospital information reviewed in August 2026, Korean particle therapy centers differ in the cancer types they list or report.
The table below is a hospital-by-hospital reference. The treating hospital reviews each case individually.
Hospital-by-Hospital Cancer Area Snapshot
Cancer Area | Yonsei Severance Carbon-ion | Samsung Medical Center Proton | National Cancer Center Proton |
Prostate cancer | ● | ● | ● |
Liver cancer / HCC | ● | ● | ● |
Pancreatic cancer | ● | ● | ● |
Lung cancer | ● | ● | ● |
Brain tumors | – | ● | ● |
Head & neck cancer | ● | ● | ● |
Esophageal cancer | – | ● | ● |
Breast cancer | – | ● | ○ |
Cervical cancer | – | – | ● |
Pediatric tumors | – | ● | ● |
Recurrent rectal cancer | ● | ● | ● |
Sarcoma, bone / soft tissue | ● | ● | ○ |
Ocular tumors | △ | – | ● |
Chordoma | – | ● | ● |
Trachea / airway cancers | – | ● | – |
Stomach / gastric cancer | – | ● | – |
Symbol Guide
Symbol | Meaning |
● | Listed on the hospital’s particle therapy website or reported as being treated |
○ | Mentioned for a limited subgroup or selected cases |
△ | Announced as a planned expansion area |
– | Not clearly listed in the reviewed hospital sources |
Yonsei Cancer Center currently reports carbon-ion treatment for prostate, pancreatic, liver, lung, head and neck cancers, sarcomas, and recurrent rectal cancer.
Clinical indications and acceptance criteria differ by center. The hospital determines suitability based on pathology, stage, tumor location and extent, prior treatment, and current condition.
APIS coordinates case submission and communication with relevant Korean hospitals for international patients.
